Awaiting critical Remdesivir safety data from companies: DCGI - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Awaiting critical Remdesivir safety data from companies: DCGI

Apart from BDR, all have entered into voluntary licensing agreements with Gilead Science, US-based patent holder of this drug. Gilead said the timeline to get Remdesivir to Indian patients will depend on licensees and aprocess it does not control.

from Industry-Economic Times
Read The Rest:economictimes...

Post Top Ad